Veritable’s Core Laboratories CLB Stock Holding History

Veritable’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,940	Closed	-$225K	–	782
2018 Q3	$225K	Buy	1,940 +273	+16%	+$30.8K	﹤0.01%	741
2018 Q2	$210K	Buy	+1,667	New	+$203K	﹤0.01%	748
2015 Q1	–	Sell	-2,045	Closed	-$246K	–	937
2014 Q4	$246K	Buy	2,045 +535	+35%	+$70.3K	0.01%	814
2014 Q3	$221K	Buy	1,510 +264	+21%	+$40.8K	﹤0.01%	875
2014 Q2	$208K	Buy	1,246 +55	+5%	+$9.79K	﹤0.01%	883
2014 Q1	$236K	Buy	+1,191	New	+$225K	0.01%	804

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Veritable's CLB Position: Q4 2018 in Review

Veritable sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 1,940 shares — an estimated $225K sold.

Veritable first reported a position in CLB in Q1 2014 and held it in 6 quarters. The position peaked at $246K in Q4 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Veritable reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Veritable sold 1,940 Core Laboratories shares in Q4 2018, an estimated $225K.
Veritable first reported a position in Core Laboratories in Q1 2014 and held it in 6 quarters.
Veritable's Core Laboratories position peaked at $246K in Q4 2014.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Veritable's 13F filing for Q4 2018, filed 14 Feb 2019.